Enzo Masci

Enzo Masci

Auto-generated profile, based on publicly available information

Enzo Masci

Diagnostic and Therapeutic Endoscopy Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2003 in Endoscopy
Verified
Journal Article
Closed access
PDF file
EME. Masci
E. Masci
AMA. Mariani
A. Mariani
SCS. Curioni
S. Curioni
PTP. A. Testoni
P. A. Testoni
Background and Study Aim: The identification of factors which increase the risk of acute pancreatitis, the most common and most severe complication of endoscopic retrograde cholangiopancreatography (ERCP), is of considerable importance. However, in four large prospective studies, the reported incidence of identified risk factors for post-ERCP pancreatitis was found to be variable. The aim of this study was to identify the most important risk factors for post-ERCP pancreatitis. Material and Methods: We performed a meta-analysis of 15 prospective clinical studies, selected out of 52 reviewed articles, in which risk factors for pancreatitis were identified. Of the 14 risk factors identified, five were patient characteristics and nine were related to the endoscopic technique. Results: When patient-related risk factors were analysed, the relative risk for suspected sphincter of Oddi dysfunction was 4.09 (95 % CI 3.37 to 4.96; P < 0.001); for female gender, 2.23 (95 % CI 1.75 to 2.84, P < 0.001); and for previous pancreatitis, 2.46 (95 % CI 1.93 to 3.12, P < 0.001). Two endoscopy-related factors were confirmed: for precut sphincterotomy the relative risk was 2.71 (95 % CI 2.02 to 3.63, P < 0.001); for pancreatic injection the relative risk was 2.2 (95 % CI 1.6 to 3.01, P < 0.001). Conclusions: This meta-analysis provides a clear basis for planning pharmacological studies or studies of new endoscopic techniques in patients at high risk of developing post-ERCP pancreatitis. Knowing which patients are most at risk may also make it easier to decide who should be considered unsuitable for same-day discharge.

26 September 1996 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
GCGiorgio Cavallini
Giorgio Cavallini
ATAlberto Tittobello
Alberto Tittobello
LFLuca Frulloni
Luca Frulloni
EMEnzo Masci
Enzo Masci
AMAlberto Mariani
Alberto Mariani
TGthe Gabexate in Digestive Endoscopy — Italian Group
the Gabexate in Digestive Endoscopy — Italian Group
Endoscopic retrograde cholangiopancreatography (ERCP) is associated with elevated levels of pancreatic enzymes and pancreatitis. Gabexate, a protease inhibitor, has been used to prevent pancreatic damage related to ERCP.

1 August 2010 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
PTPier Alberto Testoni
Pier Alberto Testoni
AMAlberto Mariani
Alberto Mariani
AGAntonella Giussani
Antonella Giussani
CVCristian Vailati
Cristian Vailati
EMEnzo Masci
Enzo Masci
LPLucia Piazzi
Lucia Piazzi
The American Journal of Gastroenterology is published by Nature Publishing Group (NPG) on behalf of the American College of Gastroenterology (ACG). Ranked the #1 clinical journal covering gastroenterology and hepatology*, The American Journal of Gastroenterology (AJG) provides practical and professional support for clinicians dealing with the gastroenterological disorders seen most often in patients. Published with practicing clinicians in mind, the journal aims to be easily accessible, organizing its content by topic, both online and in print. www.amjgastro.com, *2007 Journal Citation Report (Thomson Reuters, 2008)

1 October 2011 in Archives of Surgery
Verified
Journal Article
Open access
PDF file
GMGianpiero Manes
Gianpiero Manes
MBMario de Bellis
Mario de Bellis
LFLorenzo Fuccio
Lorenzo Fuccio
ARAlessandro Repici
Alessandro Repici
EMEnzo Masci
Enzo Masci
VCVincenzo Cennamo
Vincenzo Cennamo
One-quarter of patients with colorectal cancer (CRC) develop bowel obstruction.1 In approximately 30% of these individuals, curative resection is not feasible because of advanced disease and comorbidities. Surgical intervention in these patients usually results in later creation of colostomy, which cannot be reversed in up to 50% of the cases.2 Self-expandable metal stents (SEMSs) represent a valid alternative to operations, either as a bridge to surgical intervention or for palliation.

23 February 2013 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
RMRaffaele Manta
Raffaele Manta
Giuseppe GalloroGiuseppe Galloro
Giuseppe Galloro
BMBenedetto Mangiavillano
Benedetto Mangiavillano
RCRita Conigliaro
Rita Conigliaro
LPLuigi Pasquale
Luigi Pasquale
MFMarzio Frazzoni
Marzio Frazzoni

3 February 2010 in Journal of Digestive Diseases
Verified
Journal Article
Open access
PDF file
BMBenedetto Mangiavillano
Benedetto Mangiavillano
PVPaolo Viaggi
Paolo Viaggi
EMEnzo Masci
Enzo Masci
Iatrogenic perforations that occur during the endoscopic procedures are generally surgically managed, even if some authors prefer a non‐surgical approach in selected cases. The endoscopic application of metallic clips has been widely used in the gastrointestinal (GI) tract for hemostasis and also for marking lesions. Since 1993 several series of endoscopic perforations treated with endoclips have been described in the literature. In this review we offer a descriptive analysis of the reported cases of the acute iatrogenic perforation, describing the closure of different perforations occurring in the GI tract, treated with metallic clips.